Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene

Seema A. Khan, MD, discusses 5-year clinical outcomes from the ECOG-ACRIN E4112 trial, which is evaluating the use of MRI and a 12-gene expression assay to optimize local therapy for patients with ductal carcinoma in situ.

Related Keywords

Seemaa Khan , , Northwestern University Feinberg School Of Medicine , Bluhm Family Professor Of Cancer Research , Optimizing Local Therapy Using , Gene Expression Assay , Partnership With , Bluhm Family Professor , Cancer Research , Northwestern University Feinberg School , D , Ecog Acrin E4112 Trial , Nct02352883 , Patients With Ductal Carcinoma In Situ ,